MTOR and neoplasm: Previous studies have shown that inhibition of PI3K-Akt-mTOR pathway activity could increase cellular levels of p53 [29, 30] and enhance DNA damage-induced cell death in tumor cells through a p53-dependent manner [24, 31, 32].